Meet the team of contributing medical writers from Fox Chase Cancer Center who provide onsite reporting from major urologic meetings and conferences.
Anthony T. Corcoran, MD is a senior fellow in urologic oncology and robotic surgery at Fox Chase Cancer Center in Philadelphia, PA. Prior to his fellowship, Dr. Corcoran completed his urology residency at the University of Pittsburgh Medical Center. He will be joining the staff of SUNY Stony Brook Medical Center on the east end of New York's Long Island, specializing in urologic oncology with a focus on minimally invasive surgery.
Serge Ginzburg, MD is a Society of Urologic Oncology Fellow at the Fox Chase Cancer Center in Philadelphia, PA. He graduated from SUNY Downstate College of Medicine in Brooklyn, NY. He then successfully completed a general surgery internship and a urology residency at the University of Connecticut Health Center in Farmington, CT. Dr. Ginzburg will join Albert Einstein Medical Center in Philadelphia, where he will focus his practice on urologic oncology and robotic and minimally invasive surgery. Dr. Ginzburg’s interests include kidney, prostate, bladder, and adrenal cancers, as well as other urologic malignancies.
Reza Mehrazin, MD is a fellow of urologic oncology and robotic surgery at Fox Chase Cancer Center in Philadelphia, PA. His current practice focuses on the minimal-invasive surgical treatment of kidney, bladder, prostate, adrenal, and upper tract urothelial carcinoma. Prior to his fellowship, Dr. Mehrazin completed his general surgery internship and residency in urologic surgery at the University of Tennessee Health Science Center. During his residency, in addition to endourology, female, trauma/reconstruction, he was also trained in performing primary and salvage cryoablation of prostate cancer.
Jeffrey J. Tomaszewski, MD received his medical degree from Jefferson Medical College of Thomas Jefferson University in Philadelphia, PA. He then completed a residency in general urology at the University of Pittsburgh Medical Center School of Medicine. He is currently completing a two-year Society of Urologic Oncology accredited fellowship in urologic oncology at Fox Chase Cancer Center in Philadelphia, PA. Dr. Tomaszewski's current clinical practice focuses on the minimally-invasive treatment of kidney, prostate, bladder, and adrenal cancers, as well as salvage therapy for prostate cancer. His research interests include epigenetic regulation of carcinogenesis and identification of modifiable barriers to care access.
# # #
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA USA